Apremilast (apmilast) effects and side effects
1. Function and efficacy:
Apremilast is an oral drug that belongs to the phosphodioic acid enzyme -4 (PDE4) inhibitor class. It is mainly used to treat psoriasis and related arthritis and has the following main effects:
1.Anti-inflammatory effect: Psoriasis and related arthritis are inflammatory diseases, and their pathogenesis is related to the excessive release of inflammatory mediators. By inhibiting the activity of PDE4 enzyme, Apremilast reduces the production and release of inflammatory mediators (such as tumor necrosis factor-α, etc.), thereby alleviating the inflammatory response of the disease.
2.Improve skin symptoms: Patients with psoriasis usually present with red, scaly lesions on the skin surface, which may be accompanied by itching and pain. Treatment with Apremilast can improve these skin symptoms and reduce the size and severity of lesions.
3.Relieve arthritis symptoms: Psoriatic arthritis and psoriatic arthritis are complications of psoriasis, in which patients present with symptoms such as joint pain, swelling, and limited mobility. Treatment with Apremilast can reduce these arthritis symptoms and improve patients' joint function and quality of life.
4.Convenient oral administration: Compared with other treatment methods, Apremilast as an oral drug has a more convenient way of administration. Patients can take it at home without the need to go to the hospital for treatment regularly.

2. Side effects:
Although Apremilast has certain therapeutic effects, some side effects may occur during use. The following are common side effects of Apremilast:
1.Adverse gastrointestinal reactions: Including nausea, vomiting, diarrhea, stomach pain and other gastrointestinal discomforts. These adverse reactions are usually more common at the beginning of medication and may lessen or disappear with prolonged medication.
2.Headache: Headache symptoms may occur during Apremilast treatment, usually mild to moderate headache, and most patients can tolerate it.
3.Oral ulcers: Individual patients may develop symptoms of oral ulcers or stomatitis while using Apremilast, which may cause oral discomfort and pain.
4.Increased risk of infection: Because Apremilast affects the immune system, there may be an increased risk of infection. Patients should pay close attention to any signs of infection during use, such as fever, cough, sore throat, etc.
5.Skin reactions: Including rash, itching, dry skin and other adverse skin reactions. These reactions are usually mild, tolerated by most patients, and gradually lessen as treatment progresses.
6.Others: There are also some other less common side effects, such as dizziness, fatigue, heart palpitations, etc. Patients should pay attention to observation and communicate with their doctor in time during use.
3. Notes:
1.Before using Apremilast, patients should read the drug instructions carefully and understand the possible side effects and precautions.
2.During use, patients should communicate with the doctor in a timely manner and report any discomfort or abnormalities so that the doctor can adjust the treatment plan in a timely manner.
3.Pregnant women, lactating women and patients with severe liver and kidney damage should consult a doctor before using Apremilast to determine whether the drug is suitable for use based on the specific situation.
4.Patients should avoid using Apremilast at the same time with other immunomodulatory drugs to avoid increasing the risk of side effects.
To sum up, Apremilast, as an oral drug, has the effect of anti-inflammatory, improving skin symptoms and arthritis symptoms, but some side effects such as gastrointestinal adverse reactions, headaches, and increased risk of infection may occur during use. Patients should read the drug instructions carefully before use and use the drug correctly under the guidance of a doctor to reduce the occurrence of adverse reactions.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)